CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues
Net product revenues	$ 423,215	$ 377,755
License revenues	3,269	4,896
Total revenues	426,484	382,651
Cost of product revenues	103,149	85,872
Gross margin	323,335	296,779
Patent Monetization expenses	39,172	39,390
Research and development expenses	137,724	152,621
General, administrative and selling expenses	276,216	283,056
Operating loss	(129,777)	(178,288)
Gain from forgiveness of PPP Loan First Draw and related interest	143,641
Interest expense, net	(17,499)	(17,467)
Loss from operations before provision for income taxes	(3,635)	(195,755)
Provision for income taxes	288	506
Net loss	$ (3,923)	$ (196,261)
Basic and diluted weighted average shares	68,104,957	68,104,957
Basic and diluted net loss per share	$ (0.00)	$ (0.00)